TAPIMMUNE INC (TPIV)

Company Overview
TapImmune Inc. engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. The company focuses on conducting studies using its transporters of antigen processing (TAP) gene technology in combination with an adeno virus. Its products include TAP cancer vaccine, which is under preclinical trial used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The company was founded in 1999 and is based in Seattle, Washington.
read more

QUOTE

As of 08:48AM EDT July 25, 2014
$ 1.39   -0.05 (-3.47%)
Today's Open: 1.48 Previous Close: 1.44
Today's High: 1.48 Volume: 7,606
Today's Low: 1.39 Avg Vol: 19,890
52 Week High: 7 Bid (size): 0
52 Week Low: 0.0062 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 1551 Eastlake Avenue East, Suite 100, Seattle, WA 98102, United States
Mailing Address: -
Phone: 206-504-7279
Fax: -
Website: http//www.tapimmune.com

Company Details:

Symbol: TPIV
SIC: -
State location: A1
Sector: -
State of Inc: NV
Employees: 2
Type: -

Key executives:

Name Age Position

LATEST ARTICLES

TapImmune, Inc. (OTC:TPIV) Falls Down on Disappointing Financials April 17, 2012

Yesterday TapImmune, Inc. (OTC:TPIV) stock received new promotional coverage and the company announced a license agreement, however, the stock price did not react as expected and started falling down already at market open. The same day TRIV filed also ... read more

TapImmune, Inc. (OTC:TPIV) Jumps Up Unexpectedly November 21, 2011

On Friday TapImmune, Inc. (OTC:TPIV) stock jumped up both in share price and trading volume. There is no direct explanation for now as the latest news from the company dates back to the beginning of the month and the new financials will come out with a ... read more

TapImmune, Inc. (OTC:TPIV): Third Party Puts $45,000 on a Promotional Campaign October 24, 2011

On Friday, TapImmune, Inc. (OTC:TPIV) stock closed the market without a change in the share price, but this does not mean the market looks consolidated. For today's session, there is a new promotional campaign and a press release from Friday afternoon. read more

TapImmune, Inc. (OTC:TPIV) Climbs Gradually to the Resistance August 15, 2011

On Friday the stock of TapImmune, Inc. (OTC:TPIV) had an intensive tradings session with the share price hitting a resistance level and the volume seeing some of its highest values recently. It looks like the stock traded under the influence of the anno... read more

LATEST STOCK PROMOTIONS

** TPIV - Breast Cancer Vaccine Read Now ** Jun 12, 2014, 16:43

    Our Pick TPIV Dear Valued Subscriber,   I AM ALERTING TPIV FOR TOMORROW!!!!!   TapImmune is a clinical-stage immunotherapy specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Unlike other vaccine technologies that narrowly address the initiation of an immune read more

Promoter: openingbellreport.com Paying Party: UNKNOWN Max Profit: 5.88% Gain at close: Pending
Stock: TPIV Compensation: No compensation Avg $ Volume for Period: UNKNOWN

TPIV is 100% bottomed out with triple digit percentage gain potential! Oct 09, 2013, 08:51

V.I.P STOCK ALERTS Attention V.I.P. Traders...           Put TPIV on your radar NOW!           I feel like I owe you all a little make up after Tuesday's pick gapped down even before the open, thus ruining any reason for us to even play this time around.   Now, when I say make-up... I mean a "HOLY SH*T, lets give our subscribers something to talk about!" read more

Promoter: VIP STOCK ALERTS Paying Party: UNKNOWN Max Profit: 0.00% Gain at close: Pending
Stock: TPIV Compensation: $10,000 Avg $ Volume for Period: UNKNOWN

TPIV is 100% bottomed out with triple digit percentage gain potential! Oct 09, 2013, 08:49

  ATTENTION HUNTERS!         Put TPIV on your radar NOW!           I feel like I owe you all a little make up after Tuesday's pick gapped down even before the open, thus ruining any reason for us to even play this time around.   Now, when I say make-up... I mean a "HOLY SH*T, lets give our subscribers something to talk about!" kind of make-up.   So read more

Promoter: Stock Hunter Paying Party: UNKNOWN Max Profit: 0.00% Gain at close: Pending
Stock: TPIV Compensation: $10,000 Avg $ Volume for Period: UNKNOWN

TapImmune, Inc. (TPIV) MESSAGE BOARD

Post # Subject Re Name Date
1 TapImmune (TPIV)- STOCK TRADING HALTED... 0
2 Stop loss at? 0
3 TPIV - chart looking nice...IMO! The... 1